Surgical Navigation Systems Market worth 906.8 Million USD by 2021

on
Browse 167 market data tables and 43 figures spread through 171 pages and in-depth TOC on “Surgical Navigation Systems Market”
https://www.marketsandmarkets.com/Market-Reports/surgical-navigation-system-market-250749594.html
The global surgical navigation systems market is expected to reach USD 906.8 Million by 2021 from USD 662.5 Million in 2016, at a CAGR of 6.5% during the forecast period (2016–2021).

The growth of this market is primarily driven by factors such as rising adoption of minimally invasive surgical procedures; growing number of partnerships, agreements, and collaborations among market players; increasing incidence of orthopedic and neurological disorders; and high prevalence of ENT disorders. In addition to this, government funding for research and development activities for surgical navigation systems is also providing an impetus for the growth of this market. Moreover, acceptance of surgical navigation systems in ambulatory settings and untapped Asian economies provide significant growth opportunities in the market. However, high cost and product recalls may hinder the growth of this market during the forecast period.


In this report, the Global surgical navigation systems market is segmented on the basis of application, technology, patient care setting, and region.

Based on patient care setting, the surgical navigation systems market is segmented into hospitals and physician practices & ambulatory settings. The hospitals segment is expected to account for the largest share of the surgical navigation systems market in 2016. However, physician practices & ambulatory settings are expected to grow at the highest CAGR during the forecast period. Growing acceptance of surgical navigation systems in ambulatory settings and increasing patient preference towards clinics are some major factors that drive market growth.

The surgical navigations systems market is highly competitive with the presence of various established as well as emerging players. Some of key players in this market include Medtronic plc (Ireland), Stryker Corporation (U.S.), Brainlab AG (Germany), B. Braun Melsungen AG (Germany), Scopis GmbH (Germany), Fiagon AG (Germany), Karl Storz GmbH & Co. KG (Germany), Amplitude Surgical (France), Zimmer Biomet Holdings, Inc. (U.S.), and Siemens Healthineers (Germany). New product launches, product approvals, agreements, partnerships, and collaborations were the most-preferred growth strategies adopted by key players between 2013 and 2016.

Comments

Post a Comment